Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder
Evrim Özkorumak Karagüzel, Filiz Civil Arslan, Emel Uysal, et al.
Comprehensive Psychiatry (2018) Vol. 89, pp. 61-66
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Psychiatric face of COVID-19
Luca Steardo, Luca Steardo, Alexei Verkhratsky
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 212
Climate change, environment pollution, COVID-19 pandemic and mental health
Donatella Marazziti, Paolo Cianconi, Federico Mucci, et al.
The Science of The Total Environment (2021) Vol. 773, pp. 145182-145182
Open Access | Times Cited: 161
Defining IL‐6 levels in healthy individuals: A meta‐analysis
Elias A. Said, Iman Al‐Reesi, Nawal Al‐Shizawi, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 6, pp. 3915-3924
Closed Access | Times Cited: 138
Inflammation in obsessive–compulsive disorder: A literature review and hypothesis‐based potential of transcranial photobiomodulation
David Richer Araujo Coelho, Joshua D. Salvi, Willians Fernando Vieira, et al.
Journal of Neuroscience Research (2024) Vol. 102, Iss. 3
Closed Access | Times Cited: 12
Smo-Shh Agonist Purmorphamine Prevents Neurobehavioral and Neurochemical Defects in 8-OH-DPAT-Induced Experimental Model of Obsessive-Compulsive Disorder
Ria Gupta, Sidharth Mehan, Pranshul Sethi, et al.
Brain Sciences (2022) Vol. 12, Iss. 3, pp. 342-342
Open Access | Times Cited: 30
Obsessive-Compulsive Disorder, PANDAS, and Tourette Syndrome: Immuno-inflammatory Disorders
Donatella Marazziti, Stefania Palermo, Alessandro Arone, et al.
Advances in experimental medicine and biology (2023), pp. 275-300
Closed Access | Times Cited: 18
What Does Immunology Have to Do With Normal Brain Development and the Pathophysiology Underlying Tourette Syndrome and Related Neuropsychiatric Disorders?
Davide Martino, Isaac N. S. Johnson, James F. Leckman
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 44
Acetyl-11-keto-beta boswellic acid(AKBA) modulates CSTC-pathway by activating SIRT-1/Nrf2-HO-1 signalling in experimental rat model of obsessive-compulsive disorder: Evidenced by CSF, blood plasma and histopathological alterations
Pranshul Sethi, Sidharth Mehan, Zuber Khan, et al.
NeuroToxicology (2023) Vol. 98, pp. 61-85
Open Access | Times Cited: 14
Implications of cytokine genes polymorphisms in Jordanian patients with obsessive compulsive disorder
Ahmad M. Khalil, Manal W. Khrais, Khaled M. Al-Qaoud, et al.
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access
Lactoferrin improves cognitive function and attenuates brain senescence in aged mice
Jiaping Zheng, Yunzhen Xie, Fei Li, et al.
Journal of Functional Foods (2019) Vol. 65, pp. 103736-103736
Open Access | Times Cited: 31
COVID-19 and neurocognitive disorders
Elizabeta B. Mukaetova‐Ladinska, Golo Kronenberg, Ruma Raha‐Chowdhury
Current Opinion in Psychiatry (2020) Vol. 34, Iss. 2, pp. 149-156
Open Access | Times Cited: 29
Serum metabolites and inflammation predict brain functional connectivity changes in Obsessive-Compulsive disorder
Guoqing Chen, Xiao Hong Zhao, Minyao Xie, et al.
Brain Behavior and Immunity (2025) Vol. 126, pp. 113-125
Closed Access
A Review of Neurological Involvement in Patients with SARS-CoV-2 Infection
Yidan Xu, Zhuang Yu, Lumei Kang
Medical Science Monitor (2021) Vol. 27
Open Access | Times Cited: 21
Comparison of cognitive impairments with lipid profiles and inflammatory biomarkers in unipolar and bipolar depression
Shu-Fang Zhang, Huamin Chen, Jia-Ni Xiong, et al.
Journal of Psychiatric Research (2022) Vol. 150, pp. 300-306
Closed Access | Times Cited: 16
Syringaresinol attenuates Tau phosphorylation and ameliorates cognitive dysfunction induced by sevoflurane in aged rats
Simin Zheng, Yunpeng Teng, Hongtao Liu, et al.
Journal of Neuropathology & Experimental Neurology (2024) Vol. 83, Iss. 7, pp. 596-605
Open Access | Times Cited: 2
Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) and Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS): Immunological Features Underpinning Controversial Entities
Lucia Leonardi, C Perna, Irene Bernabei, et al.
Children (2024) Vol. 11, Iss. 9, pp. 1043-1043
Open Access | Times Cited: 2
In pursuit of biomarkers for predicting susceptibility to activity‐based anorexia in adolescent female rats
Laura K Milton, Timothy Patton, Meredith O’Keeffe, et al.
International Journal of Eating Disorders (2022) Vol. 55, Iss. 5, pp. 664-677
Open Access | Times Cited: 11
Gastrointestinal, Liver, Pancreas, Oral and Psychological Long-term Symptoms of COVID-19 After Recovery: A Review
Reza Afrisham, Yasaman Jadidi, Maryam Davoudi, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 7, pp. 852-868
Closed Access | Times Cited: 10
Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorder
Vera Nezgovorova, Casara Jean Ferretti, Stefano Pallanti, et al.
Journal of Psychiatric Research (2021) Vol. 149, pp. 367-373
Open Access | Times Cited: 14
Expression of immune-related proteins and their association with neuropeptides in adolescent patients with anorexia nervosa
Marta Tyszkiewicz‐Nwafor, Katarzyna Jowik, Elżbieta Paszyńska, et al.
Neuropeptides (2021) Vol. 91, pp. 102214-102214
Closed Access | Times Cited: 13
Implication of microbiota gut-brain axis in the manifestation of obsessive-compulsive disorder: Preclinical and clinical evidence
Sonali R. Kamble, Manoj P. Dandekar
European Journal of Pharmacology (2023) Vol. 957, pp. 176014-176014
Closed Access | Times Cited: 5
Searching for host immune-microbiome mechanisms in obsessive-compulsive disorder: A narrative literature review and future directions
Emily A. Troyer, Jordan N. Kohn, Gertrude Ecklu-Mensah, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 517-534
Open Access | Times Cited: 11
Association Between Inflammatory Cytokines, Executive Function, and Substance Use in Patients With Opioid Use Disorder and Amphetamine-Type Stimulants Use Disorder
Tzu‐Yun Wang, Ru‐Band Lu, Sheng-Yu Lee, et al.
The International Journal of Neuropsychopharmacology (2022) Vol. 26, Iss. 1, pp. 42-51
Open Access | Times Cited: 8
Comparison of autogenous and reactive type obsessive-compulsive disorders in terms of clinical characteristics: A meta-analysis study
Bengü Yücens, Nilgün Oktar Erdoğan, Muhammet Gündüz, et al.
Journal of Psychiatric Research (2024) Vol. 176, pp. 338-347
Closed Access | Times Cited: 1
Exploring the role of interleukin-1β and interleukin-6 in the pathophysiology of obsessive-compulsive disorder
Nisat Sarmin, A. S. M. Roknuzzaman, Rapty Sarker, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0306125-e0306125
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top